MedTrace Logo

Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes

NCT04072978 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-11-27

No results posted yet for this study

Summary

This is a prospective comparative non-randomized cohort study to understand the long-term vision outcomes, safety, and stability of anterior chamber intraocular lenses (AC IOLs) vs. scleral-fixated intraocular lenses (SF IOLs).

Conditions

  • Corneal Endothelial Cell Loss
  • Secondary Intraocular Lens

Interventions

DEVICE

Intraocular lens implantation

Implantation of an intraocular lens using either an anterior chamber IOL or a scleral fixated IOL using the modified Yamane technique.

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Peter Kertes, MD · Sunnybrook Hospital

Eligibility

Min Age
16 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2024-12-30
Completion
2025-01-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04072978 on ClinicalTrials.gov